ConductScience.org, home

Paper28879693

Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.

Gabrielson AT and 2 others. World J Mens Health, 2017. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option. Papers, record 28879693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28879693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.
PubMed
Journal
World J Mens Health
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2020-10-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gabrielson ATAndrew Thttps://orcid.org/0000-0001-9971-9813
2Alzweri LMLaith Mhttps://orcid.org/0000-0001-8467-2688
3Hellstrom WJWayne Jghttps://orcid.org/0000-0003-1284-959X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123376148Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.J Urol2013https://conductscience.org/library/papers/23376148PubMed
26291216Collagenase for Peyronie's disease experimental studies.Urol Res1982https://conductscience.org/library/papers/6291216PubMed
39523668Histological and ultrastructural alterations in an animal model of Peyronie's disease.Br J Urol1998https://conductscience.org/library/papers/9523668PubMed
41895413The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.J Urol1991https://conductscience.org/library/papers/1895413PubMed
510799245A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.J Urol2000https://conductscience.org/library/papers/10799245PubMed
617367443Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.J Sex Med2007https://conductscience.org/library/papers/17367443PubMed
727544298Review of Management Options for Patients With Atypical Peyronie's Disease.Sex Med Rev2017https://conductscience.org/library/papers/27544298PubMed
89586617Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.Urology1998https://conductscience.org/library/papers/9586617PubMed
916094040Peyronie's disease in diabetic patients being screened for erectile dysfunction.J Urol2005https://conductscience.org/library/papers/16094040PubMed
1027211926Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms.Urology2016https://conductscience.org/library/papers/27211926PubMed
1125388099Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.J Sex Med2015https://conductscience.org/library/papers/25388099PubMed
1227816605Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease.Urology2017https://conductscience.org/library/papers/27816605PubMed
1328612401Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.BJU Int2017https://conductscience.org/library/papers/28612401PubMed
1420666587Collagenase clostridium histolyticum for Dupuytren's contracture.Expert Opin Biol Ther2010https://conductscience.org/library/papers/20666587PubMed
1520500447Peyronie's disease following radical prostatectomy: incidence and predictors.J Sex Med2010https://conductscience.org/library/papers/20500447PubMed
1612686831Tunica albuginea tissue analysis after electromotive drug administration.J Urol2003https://conductscience.org/library/papers/12686831PubMed
1715626876Peyronie's disease: advancements in recent surgical techniques.Curr Opin Urol2004https://conductscience.org/library/papers/15626876PubMed
1815126819Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.J Urol2004https://conductscience.org/library/papers/15126819PubMed
194366338Toxicity of collagenase: the relation to enzyme therapy of disk herniation.Clin Orthop Relat Res1974https://conductscience.org/library/papers/4366338PubMed
202544990Microvascular response to locally injected collagenase. An experimental investigation in hamsters and rabbits.Scand J Plast Reconstr Surg Hand Surg1989https://conductscience.org/library/papers/2544990PubMed

See all 63 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
40314553Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil.Asian J Androl2025https://conductscience.org/library/papers/40314553PubMed
36351188Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months.Aesthet Surg J2023https://conductscience.org/library/papers/36351188PubMed
36211476Collagenase Clostridium histolyticum for the Treatment of Cellulite in the Buttocks and Thigh: Early Insights From Clinical Practice.Aesthet Surg J Open Forum2022https://conductscience.org/library/papers/36211476PubMed
34552787Peyronie's disease - outcomes of collagenase clostridium histolyticum injection: A systematic review.Arab J Urol2021https://conductscience.org/library/papers/34552787PubMed
33735499Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH-aaes).J Cosmet Dermatol2021https://conductscience.org/library/papers/33735499PubMed
31093703Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.World J Urol2020https://conductscience.org/library/papers/31093703PubMed
30929330Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study.World J Mens Health2019https://conductscience.org/library/papers/30929330PubMed
30792820Non-invasive treatment in the management of Peyronie's disease.Ther Adv Urol2019https://conductscience.org/library/papers/30792820PubMed
29706035Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque.World J Mens Health2018https://conductscience.org/library/papers/29706035PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28879693

GET https://conductscience.org/api/papers/v1/28879693/references?page=2